FDAnews
www.fdanews.com/articles/205294-co-diagnostics-gets-uk-approval-for-logix-smart-covid-19-2-gene-test

Co-Diagnostics Gets UK Approval for Logix Smart COVID-19 2-Gene Test

November 11, 2021

Molecular diagnostics company Co-Diagnostics’ Logix Smart SARS-CoV-2 2-gene multiplex test has been validated for sale in the UK by the UK Health Security Agency (UKHSA).

The UKHSA is the agency responsible for planning, preventing and responding to external health threats, having replaced Public Health England earlier this year.

The Logix Smart test kit is an in vitro diagnostic test that does qualitative detection of the RNA from the SARS-CoV-2 coronavirus that causes COVID-19. Salt Lake City, Utah-based Co-Diagnostics has developed a number of PCR-based tests for COVID-19 based on its patented CoPrimer platform.

View today's stories